---
accession : E-GEOD-24065
platform  : A-AGIL-28
pathway   : p53
cells     : MCF7 cells grown in estrogen-depleted conditions
treatment : doxorubicin
effect    : activating
hours     : 10

control   :
    - GSM591738 1
    - GSM591755 1
    - GSM591756 1
    - GSM591757 1
    - GSM591758 1
    - GSM591759 1
perturbed :
    - GSM591760 1
    - GSM591773 1
    - GSM591774 1
    - GSM591775 1
    - GSM591776 1
    - GSM591777 1
    - GSM591778 1

---
accession : E-GEOD-24065
platform  : A-AGIL-28
pathway   : p53
cells     : MCF7 cells grown in physiological estrogen conditions
treatment : doxorubicin
effect    : activating
hours     : 10

control   :
    - GSM591791 1
    - GSM591794 1
    - GSM591795 1
perturbed :
    - GSM592126 1
    - GSM592127 1
    - GSM592128 1

---
accession : E-GEOD-24065
platform  : A-AGIL-28
pathway   : p53
cells     : MCF7 cells grown in pharmacological estrogen conditions
treatment : doxorubicin
effect    : activating
hours     : 10

control   :
    - GSM591780 1
    - GSM591789 1
    - GSM591790 1
perturbed :
    - GSM591813 1
    - GSM591814 1
    - GSM591816 1

---
accession : E-GEOD-24065
platform  : A-AGIL-28
pathway   : p53
cells     : MCF7 cells treated with TNFa
treatment : doxorubicin
effect    : activating
hours     : 10

control   :
    - GSM591802 1
    - GSM591807 1
    - GSM591810 1
perturbed :
    - GSM592132 1
    - GSM592133 1
    - GSM592134 1
...
